加和国际控股(08513) - 2022 Q1 - 季度财报

Financial Performance - For the three months ended March 31, 2022, the group's unaudited revenue was approximately SGD 3.9 million, a decrease of about SGD 1.2 million or 23.5% compared to SGD 5.1 million for the same period in 2021[5]. - The group recorded an unaudited loss of approximately SGD 205,000 for the three months ended March 31, 2022, compared to a loss of approximately SGD 62,000 for the same period in 2021[5]. - Gross profit for the three months ended March 31, 2022, was SGD 714,000, down from SGD 1.145 million in the same period of 2021[7]. - Operating loss for the three months ended March 31, 2022, was SGD 52,000, compared to an operating profit of SGD 50,000 for the same period in 2021[7]. - The total comprehensive loss for the three months ended March 31, 2022, was SGD 189,000, compared to a loss of SGD 38,000 for the same period in 2021[10]. - The group reported a basic and diluted loss per share of SGD 0.04 for the three months ended March 31, 2022[10]. - The company reported a net loss attributable to equity holders of SGD 185,000 for the three months ended March 31, 2022, compared to a loss of SGD 3,000 in 2021[33]. - Basic and diluted loss per share for the first quarter of 2022 was SGD (0.04), compared to an insignificant amount in 2021[33]. - The net loss for the same period was approximately SGD 205,000, compared to a net loss of approximately SGD 62,000 in the previous year, indicating an increase in losses due to a decrease in sales orders for disposable medical device components[42]. Revenue and Costs - Revenue for the three months ended March 31, 2022, was SGD 3,934,000, a decrease of 22.6% from SGD 5,084,000 in the same period of 2021[20]. - Cost of goods sold for the same period was SGD 1,550,000, down 25.4% from SGD 2,077,000 in 2021[22]. - The cost of sales decreased by approximately SGD 0.7 million or 17.9% to about SGD 3.2 million, consistent with the decrease in revenue[46]. Expenses - The group incurred administrative expenses of SGD 648,000 for the three months ended March 31, 2022, down from SGD 994,000 in the same period of 2021[7]. - Employee benefits expense decreased to SGD 1,222,000 from SGD 1,557,000, reflecting a reduction of 21.5%[22]. - Depreciation of property, plant, and equipment was SGD 112,000, down from SGD 139,000, a decrease of 19.4%[22]. - Interest expenses for the three months ended March 31, 2022, totaled SGD 42,000, down from SGD 61,000 in 2021, a reduction of 31.1%[23]. - Administrative expenses were reduced by approximately SGD 0.4 million or 40.0% to about SGD 0.6 million, primarily due to decreased R&D costs and the absence of administrative expenses from the disposed Chinese wine trading business[48]. Other Income and Grants - Other income for the three months ended March 31, 2022, was SGD 45,000, slightly up from SGD 43,000 in the same period of 2021[7]. - The company received government grants amounting to SGD 34,000, compared to SGD 30,000 in the previous year[20]. Dividends - The board of directors did not recommend the payment of dividends for the three months ended March 31, 2022, consistent with the previous year[5]. - The company does not recommend the payment of an interim dividend for the three months ended March 31, 2022, compared to no dividend in the same period last year[37]. Corporate Governance and Compliance - The company has complied with the corporate governance code, except for the separation of the roles of Chairman and CEO, which is currently held by the same individual[67]. - The audit committee has reviewed the unaudited financial information for the three months ended March 31, 2022, and confirmed compliance with applicable accounting standards and GEM listing rules[71]. Market Outlook - The company anticipates that the recovery of international trade and the global economy will continue, although challenges remain due to the ongoing war between Ukraine and Russia, as well as uncertainties from the COVID-19 pandemic[43]. - The company aims to continue exploring new business opportunities and optimizing resource utilization to ensure the resilience of its core business[43]. Share Information - The company has a total of 133,400,000 shares held by the beneficial owner, representing 28.00% of the total shares[58]. - The company has adopted a share option scheme allowing for the issuance of 40,000,000 share options, which accounts for approximately 8.4% of the total issued shares as of March 31, 2022[62]. - No share options were granted during the three months ended March 31, 2022, and there were no unexercised share options as of that date[65]. Foreign Exchange - The group experienced a foreign exchange loss of SGD 16,000 for the three months ended March 31, 2022, compared to a loss of SGD 24,000 for the same period in 2021[10].